Metastatic RCC, Progressing on Multiple Therapies
EP. 1: A 70-Year-Old Woman With Metastatic RCC
Watch
EP. 2: Options for mRCC After Nivolumab
EP. 3: Selecting Therapy for Progressive mRCC
EP. 4: The Rationale for Using Cabozantinib
EP. 5: Sequencing Strategies in mRCC
